1 October 2019 News
Medical technology firm Senseonics has completed patient enrolment in the Eversense PROMISE 180-day sensor clinical study of Eversense continuous glucose monitoring (CGM) system in people with diabetes.
30 September 2019 News
Researchers at the University of Exeter in the UK have created a new calculator to accurately diagnose and classify patients with type 1 or type 2 diabetes
16 September 2019 News
Abbott and Sanofi are partnering to integrate their glucose sensing and insulin delivery technologies, with ambitions to simplify how people with diabetes manage their condition.
23 August 2019 News
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Drawbridge Health’s OneDraw A1C Test System.
21 June 2019 News
University of Virginia’s (UVA) Center for Diabetes Technology (CDT) has licensed Klue's gesture sensing and behavioural analytics software for a proposed clinical trial to further diabetes treatment.
18 June 2019 News
Abbott has announced the availability of its Afinion HbA1c Dx assay for use on the Afinion 2 Analyzer and the Afinion AS100 Analyzer in the diagnosis of diabetes.
31 May 2019 Comment
There is a large established need for improved blood sugar tests, and continuous glucose monitoring (CGM) systems are set to fill this need.
26 February 2019 Sponsored
The new EU MDR raises a lot of uncertainty and concerns for manufacturers. Kim Trautman, NSF International executive vice-president, talks about the challenges for the industry and how these can...